Instrument Inactif

Communiqués AMAG Pharmaceuticals, Inc.

Actions

AMAG

US00163U1060

Produits pharmaceutiques

Communiqués

15/12/20	AMAG Pharmaceuticals : Files Submission in Response to the Food and Drug Administration's Notice of Opportunity for a Hearing and Proposal to Withdraw Approval of Makena	AQ
14/12/20	AMAG Pharmaceuticals : Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)	PU
17/11/20	AMAG PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifica (form 8-K)	AQ
17/11/20	AMAG PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifica (form 8-K)	AQ
16/11/20	AMAG Pharmaceuticals : Covis Group Completes Acquisition of AMAG Pharmaceuticals	AQ
16/11/20	AMAG Pharmaceuticals : Covis Group Completes Acquisition of AMAG Pharmaceuticals	PR
06/11/20	AMAG PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations: (form 10-Q)	AQ
15/10/20	AMAG PHARMACEUTICALS : REQUESTS HEARING TO MAINTAIN MAKENA AS A TREATMENT OPTION FOR CLINICALLY INDICATED PREGNANT PATIENTS	AQ
15/10/20	AMAG Pharmaceuticals : Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.	AQ
14/10/20	AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients	GL
14/10/20	AMAG Pharmaceuticals : Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients	AQ
09/10/20	AMAG PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AMAG Pharmaceuticals, Inc. - AMAG	BU
06/10/20	AMAG Pharmaceuticals : Provides Update on FDA's Proposal Regarding Makena	AQ
06/10/20	AMAG PHARMACEUTICALS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/10/20	AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)	GL
06/10/20	AMAG Pharmaceuticals : Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)	AQ
02/10/20	AMAG Pharmaceuticals : Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals	AQ
01/10/20	AMAG PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
01/10/20	Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals	GL
01/10/20	AMAG Pharmaceuticals : Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals	AQ
15/09/20	AMAG PHARMACEUTICALS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	AQ
10/09/20	AMAG Pharmaceuticals : to Participate in H.C. Wainwright 22nd Annual Global Investment Conference	AQ
09/09/20	AMAG Pharmaceuticals : to Participate in H.C. Wainwright 22nd Annual Global Investment Conference	AQ
09/09/20	AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment Conference	GL
17/08/20	AMAG PHARMACEUTICALS, INC. : Other Events (form 8-K)	AQ